SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is trending as traders discuss its potential breakout, with community members pointing to bullish formations and historical patterns. The conversation includes speculation about a potential 'golden cross' and the impact of increased privacy features. Some traders express concern about its historical performance relative to Bitcoin and other altcoins, while others suggest it is undervalued.

Oscar Health, Inc. is a health insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

OSCR is trending amid speculation around the extension of ACA subsidies and its potential impact on the company's business model, particularly as the government shutdown lingers. Community members are weighing bullish and bearish takes related to potential outcomes of the ACA negotiations, with some suggesting a Trump proposal could benefit Oscar's focus on the individual market. Discussions also highlight long-term consolidation patterns and potential breakout targets for the stock.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media (DJT) is trending amid ongoing political debates and discussions around government shutdowns and economic policies. The community is heavily engaged in partisan arguments, with discussions ranging from healthcare and immigration to the release of the Epstein files. Investors and commentators are also weighing in on the stock's financial performance and potential for manipulation.

Concordium is the Layer-1 blockchain built for a new era of digital trust. With mandatory, privacy-preserving identity verification built into its consensus layer, utilizing zero-knowledge proof technology. Concordium also enables Protocol-level tokens that eliminate smart contract risks by being issued directly at the consensus layer, with built-in features that provide the infrastructure for compliance-ready use cases. At its core is Smart Money - programmable, identity-embedded, and compliance-ready value that powers trusted interactions across Web3. Smart Money enables frictionless exchange, automation, and verifiable trust by design. Unlike conventional blockchains, Concordium integrates trust, accountability, and privacy into its architecture from the ground up  bridging traditional systems and Web3 to build a transparent, sustainable digital future. The name Concordium comes from the Latin concordia—meaning harmony and agreement—a reflection of its mission to build infrastructure that embeds trust, privacy, and compliance into every interaction.

Concordium

Concordium ($CCD) is trending as community members highlight its focus on regulatory compliance and privacy-preserving technology, positioning it as a leader in the emerging PayFi sector. Recent partnerships, including integration with bitcoin.com, are fueling excitement around its potential for real-world adoption and verifiable transactions. Community discussions also emphasize Concordium's unique ID layer and its potential to bridge Web2 institutions with Web3.

P8BCI Is the CCM Creator Capital Markets Creator token created by Nick Wray, intended to form a community for talking about his journey with ALS, his experiences with Telepathy BCI experiments, as well as his experiences and journey through the Solana blockchain, and cryptocurrency world of Web 3. In addition to this, prior to his progression of ALS Nick was an avid drummer, a creative, and an enjoyer of philosophical discussion - and enabled now by his BCI explores creating, and in addition to sharing his story, interacting with the community forming around his experiences.

Telepath8

Telepath8 ($P8BCI) is trending due to community excitement surrounding its developer, Nick Wray, and his Neuro Link technology. The community highlights Wray's innovative, hands-free development approach and speculation around potential connections with Tesla and Elon Musk are fueling bullish sentiment.

$SWEAT is the beating heart of the Movement Economy—a groundbreaking token that transforms physical activity into real-world value. Minted through movement, $SWEAT rewards your steps with a crypto asset that you can earn, trade, or grow. The team states that their app has increased their users’ physical activity by an average of 20%, creating a healthier society and reducing burdens on global healthcare systems. With over 20 million holders, SWEAT is eliminating barriers and making Web3 accessible to everyone, one step at a time.

Sweat Economy

Sweat Economy is trending as community members discuss its potential for mainstream adoption and its unique approach to incentivizing healthy lifestyles. The project's token burns and multi-chain functionality are also sparking interest, along with anticipation for future growth. Many users express long-term bullish sentiment, while highlighting that patience is key for this token.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group ($UNH) is trending amid concerns surrounding government healthcare policy and potential impacts on the insurance sector. Community discussions revolve around Trump's comments on healthcare and their possible effects on UNH, with some anticipating volatility and others seeing opportunity. Investors are also awaiting updates on Berkshire Hathaway's position in UNH and the status of a DOJ case, contributing to uncertainty.

Internet Computer (IC) is the world’s first blockchain that is capable of running at web speed at unrestrictive capacities. Built by the DFINITY Foundation, IC aims to recreate the web by supporting smart contract development at scale and changing the way people can interact using web services. Internet Computer aims to extend the public internet, so that it can be the world’s computing platform, in a decentralized manner. Internet Computer sets to revolutionalize the design of the crypto economy, with an aim to overhaul traditional software services.   The project was founded in October 2016 by Dominic WIllams and have raised a total of $121 million from investors such as Adreessen Horowitz, Polychain Capital, Multicoin Capital and such. On May 10, 2021, DFINITY launched the Internet Computer into the public domain, marking it a major milestone for ICP as it means the internet now functions as a decentralised global computer. This is marked by the release of all of the Internet Computer’s source code into the public domain, as well as ICP utility token that allows tens of thousands of community members to govern the Internet Computer network.  ICP is Internet Computer's native token. It plays three prominent roles:  1. Network Governance: Users that participate in the governance will be rewarded with ICPI 2. Production of Cycles for Compute: ICP can be converted into cycles where it is used as the transaction fee to access the network. Cycles are burned after used. 3. Rewarding Users: ICP is used as the rewards to incentivize users to participate in the network such as securing the network.

Internet Computer

Internet Computer (ICP) is trending due to community excitement around potential catalysts and a renewed interest in altcoins with real utility, as traders discuss significant price momentum and speculate on further gains. Talk centers around big players loading up, and the possibility of breaking through key resistance levels. Some community members are comparing its potential to previous runs of coins like ZEC.

Globe Life, Inc. is an insurance holding company, which engages in the provision of individual life and supplemental health insurance products and services. It operates through the following segments: Life Insurance, Health Insurance, and Investments Insurance. The Life Insurance segment offers products marketed by Globe Life include traditional whole life and term life insurance. The Health Insurance segment is involved in the renewable and includes Medicare Supplement, cancer, critical illness, accident, and other limited-benefit supplemental hospital and surgical products. The Investments Insurance segment refers to the management of capital resources, including investments, and the management of liquidity. The company was founded on November 19, 1979, and is headquartered in McKinney, TX.

Globe Life Inc

Globe Life is trending as the community analyzes recent Q3 earnings, which beat expectations despite some debate over revenue drivers. Analysts are updating price targets, with some raising their outlook while others are more cautious about expenses and debt. Investors are also weighing new signals and potential buying opportunities based on technical analysis and options alerts.

Moonwell Artemis uses battle tested code from the Moonwell Apollo protocol to provide an open, non-custodial lending and borrowing DeFi protocol. While Apollo is a community driven protocol with innovative features, Artemis users will enjoy polished features with faster transaction times, while still preserving the same level of security.  Moonwell’s goal is to be the most user-friendly, fast, and secure DeFi protocol in the ecosystem. With this in mind, an emphasis was placed on having a high standard of security. Multi-signature systems are implemented for all smart contracts used by the protocol, with the expert cyber-security team at Halborn Security auditing all contracts before deployment. Additionally, there is a generous bounty program through a partnership with the trusted team at ImmuneFi, which allows security researchers to submit their findings for review and earn a bounty for discovering security vulnerabilities.

Moonwell

Moonwell ($WELL) is experiencing volatility, with an oracle exploit causing a recent loss and sparking community discussion around its future. Despite holders feeling "bruised" and the token being down significantly from its ATH, some see it as a buying opportunity, while others express frustration with its performance, especially compared to other BASE ecosystem tokens.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Taiho Oncology and Cullinan Therapeutics Present Data on Zipalertinib in Patients with NSCLC with EGFR mutations and Active Brain Metastases at the ESMO Congress 2025

Taiho Oncology and Cullinan Therapeutics Present Data on Zipalertinib in Patients with NSCLC with EGFR mutations and Active Brain Metastases at the ESMO Congress 2025 Taiho Oncology and Cullinan...

BDTX vs. Cullinan Therapeutic: Which EGFR Challenger Is the Better Buy? 

BDTX and Cullinan advance next-gen EGFR inhibitors, but silevertinib's potential and valuation tilt momentum toward BDTX.

Shares of Cullinan Therapeutics Inc. fell in after-hours trading despite the company announcing a licensing agreement with Genrix Bio to develop velinotamig, a clinical-stage BCMA-directed bispecific T cell engager, for autoimmune diseases.The stock closed 1.2% higher at $9.07 on Tuesday before slipping 5.7% to $8.55 in after-hours trading.The deal grants Cullinan exclusive global rights, excluding Greater China, to velinotamig across all indications, with a $20 million upfront payment and potential milestone and royalty payments exceeding $692 million.&nbsp;The addition of velinotamig expands Cullinan’s autoimmune pipeline, alongside its CD19-targeting TCE, and is expected to support the company’s cash runway into 2028.Cullinan plans to leverage data from Genrix’s upcoming Phase 1 study in China to accelerate global development.&nbsp;CEO Nadim Ahmed said velinotamig could offer a “precise and potentially disease-modifying approach” by targeting self-reactive plasma cells implicated in certain autoimmune diseases.On Stocktwits, retail sentiment was ‘neutral’ amid ‘high’ message volume.The stock has declined 26.8% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Portrait of a doctor woman on the background of stock charts. | Image source: Getty Images

Cullinan Therapeutics Stock Slides After-Hours Despite $692M Autoimmune Drug Pact With Genrix

Cullinan Therapeutics secured global rights, excluding Greater China, to velinotamig from Genrix Bio, expanding its autoimmune pipeline with a second T cell engager. 

Equity

Taiho Pharmaceutical, Taiho Oncology, and Cullinan Therapeutics Announce Primary Endpoint Met in Phase 2b Trial of Zipalertinib in Patients with Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations Who Have Received Prior Therapy

Taiho Pharmaceutical, Taiho Oncology, and Cullinan Therapeutics Announce Primary Endpoint Met in Phase 2b Trial of Zipalertinib in Patients with Non-Small Cell Lung Cancer Harboring EGFR Exon 20...

UnitedHealth Reports Upbeat Earnings, Joins Cullinan Oncology, Ericsson And Other Big Stocks Moving Higher On Tuesday

U.S. stocks were mostly higher, with the Dow Jones index gaining over 100 points on Tuesday.
read more...

Commit To Purchase Cullinan Oncology At $7.50, Earn 6.2% Annualized Using Options

Investors eyeing a purchase of Cullinan Oncology Inc (CGEM) stock, but tentative about paying the going market price of 17.15/share, might benefit from considering selling puts among the...

Cullinan Oncology (CGEM, $17.03) Aroon Indicator entered a Downtrend on March 28, 2024.

For the last three days, A.I.dvisor has detected that CGEM's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...

Cullinan Oncology (CGEM, $17.74) Aroon Indicator entered a Downtrend on March 27, 2024.

Cullinan Oncology (CGEM, $16.78) entered Downtrend as Momentum indicator drops below 0 level on Mar 26, 2024

This indicator may be signaling that CGEM's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

Cullinan Oncology (CGEM, $15.5) Aroon Indicator entered a Downtrend on March 19, 2024.

Cullinan Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the developing of oncology and immuno-oncology therapies. Its pipeline includes CLN-978, CLN-619, Zipalertinib CLN-081/TAS6417, CLN-049, and CLN-617. The company was founded by Patrick A. Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.

Cullinan Therapeutics Inc

$ASTS

$RKLB

$BBAI

$NBIS

Which earnings release are you most excited for the week of Nov. 10? 
 
Drop a comment for others.

CGEM
Cullinan Oncology Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest CGEM News

CGEMCullinan Oncology Inc